FULTRESSE
Live / Allowed — Notice of allowance issued (as of 07 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Nov 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98846759
- Mark type
- Stylized text
- Filed
- 11 Nov 2024
- Published for opposition
- 03 Jun 2025
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: Medicated dermatological preparations and substances; Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, circulatory, dermatological, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmic, psychiatric and viral diseases and disorders; Pharmaceutical preparations for the treatment of alopecia, blood disorders, bone growth disorders, skin disorders, sleep disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives
Owner
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, US
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, US
Prosecution history
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Feb 2025 — NON-FINAL ACTION E-MAILED
- 05 Feb 2025 — NON-FINAL ACTION WRITTEN
- 05 Feb 2025 — ASSIGNED TO EXAMINER
- 11 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Nov 2024 — NEW APPLICATION ENTERED